Liang Guo

Liang Guo


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

27 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
DYDong Yang
Dong Yang
WGWen Guo
Wen Guo
LGLiang Guo
Liang Guo
Therapeutic stagnation in Alzheimer’s disease (AD) highlights the role of non-genetic mechanisms like metabolic dysregulation. We propose a paradigm: exercise reprograms phosphoglycerate dehydrogenase (PHGDH) from a pathogenic nuclear transcription factor to a protective cytoplasmic metabolic enzyme through brain-periphery crosstalk. Under AD-associated stress, PHGDH translocate to the nucleus, where its helix-turn-helix (HHTH) domain activates pro-inflammatory genes (e.g., IKKα, HMGB1), suppresses autophagy, and accelerates Aβ deposition. Centrally, exercise-induced myokine irisin suppresses PHGDH nuclear translocation via AMPK/PGC-1α signaling, preserving its metabolic role. Peripherally, exercise inhibits PHGDH in hepatic Kupffer cells, reducing systemic IL-1β release and neuroinflammation. Notably, the HHTH-targeting inhibitor NCT-503 reduces Aβ plaques by 44–62% in APP-KI mice, validating this strategy. This framework positions exercise as a precision intervention, enabling novel diagnostics (e.g., PET probes for PHGDH compartmentalization) and synergistic “exercise-pharmacotherapy.”